These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 16621074)

  • 1. Gene patents, health care policy and licensing schemes.
    Caulfield T; von Tigerstrom B
    Trends Biotechnol; 2006 Jun; 24(6):251-4. PubMed ID: 16621074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patenting Foundational Technologies: Lessons From CRISPR and Other Core Biotechnologies.
    Feeney O; Cockbain J; Morrison M; Diependaele L; Van Assche K; Sterckx S
    Am J Bioeth; 2018 Dec; 18(12):36-48. PubMed ID: 31159699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patents & public health: international trade obligations and domestic policy development.
    Amani B
    Health Law Can; 2002 Feb; 22(3):76-84. PubMed ID: 11915591
    [No Abstract]   [Full Text] [Related]  

  • 4. DNA as patentable subject matter and a narrow framework for addressing the perceived problems caused by gene patents.
    Schilling SH
    Duke Law J; 2011 Dec; 61(3):731-73. PubMed ID: 22165443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics.
    Aymé S; Matthijs G; Soini S;
    Eur J Hum Genet; 2008 May; 16 Suppl 1():S10-9. PubMed ID: 18432281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Much ado about gene patents: the role of foreseeability.
    Gulliford MJ
    Seton Hall Law Rev; 2004; 34(2):711-45. PubMed ID: 15115032
    [No Abstract]   [Full Text] [Related]  

  • 7. Compulsory licensing to regulated licensing: effects on the conflict between innovation and access in the pharmaceutical industry.
    Gillat A
    Food Drug Law J; 2003; 58(4):711-40. PubMed ID: 15027457
    [No Abstract]   [Full Text] [Related]  

  • 8. Statement on the scope of gene patents, research exemption, and licensing of patented gene sequences for diagnostics.
    Human Genome Organisation (HUGO), Ethics Committee
    J Int Bioethique; 2003; 14(3-4):201-5. PubMed ID: 15281208
    [No Abstract]   [Full Text] [Related]  

  • 9. The link between publicly funded health care and compulsory licensing.
    Hollis A
    CMAJ; 2002 Oct; 167(7):765-6. PubMed ID: 12389839
    [No Abstract]   [Full Text] [Related]  

  • 10. Licensing research tool patents.
    Flattmann GJ; Kaplan JM
    Nat Biotechnol; 2002 Sep; 20(9):945-7. PubMed ID: 12205511
    [No Abstract]   [Full Text] [Related]  

  • 11. Brazil's AIDS controversy: antiretroviral drugs, breaking patents, and compulsory licensing.
    Marques UR; Guimarães VS; Sternberg C
    Food Drug Law J; 2005; 60(3):471-7. PubMed ID: 16304752
    [No Abstract]   [Full Text] [Related]  

  • 12. A modest proposal to amend the Patent Code 35 U.S.C. Section 287(c) to allow health care providers to examine their patients' DNA.
    Minwalla S
    South Ill Univ Law J; 2002; 26(3):471-504. PubMed ID: 16485364
    [No Abstract]   [Full Text] [Related]  

  • 13. Compulsory licensing of patents in India.
    Chaudhry R
    Pharm Pat Anal; 2016 Sep; 5(6):401-406. PubMed ID: 27805847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy.
    Paradise J
    Food Drug Law J; 2004; 59(1):133-54. PubMed ID: 15190928
    [No Abstract]   [Full Text] [Related]  

  • 15. Genes and patent policy: rethinking intellectual property rights.
    Andrews LB
    Nat Rev Genet; 2002 Oct; 3(10):803-8. PubMed ID: 12360238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Models for facilitating access to patents on genetic inventions.
    Van Overwalle G; van Zimmeren E; Verbeure B; Matthijs G
    Nat Rev Genet; 2006 Feb; 7(2):143-8. PubMed ID: 16385347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International conflicts over patenting human DNA sequences in the United States and the European Union: an argument for compulsory licensing and a fair-use exemption.
    Gitter DM
    N Y Univ Law Rev; 2001 Dec; 76(6):1623-91. PubMed ID: 12741387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patenting and licensing in genetic testing: ethical, legal, and social issues.
    Soini S; Aymé S; Matthijs G;
    Eur J Hum Genet; 2008 May; 16 Suppl 1():S10-50. PubMed ID: 18557182
    [No Abstract]   [Full Text] [Related]  

  • 19. Public access versus proprietary rights in genomic information: what is the proper role of intellectual property rights?
    Mueller JM
    J Health Care Law Policy; 2003; 6(2):222-40. PubMed ID: 15017961
    [No Abstract]   [Full Text] [Related]  

  • 20. The Legislative Approach and System Improvement of China's Compulsory Licensing for Drug Patents.
    Cao Z; Chen Y; Jiang W; Li W
    Drug Des Devel Ther; 2021; 15():3717-3731. PubMed ID: 34511881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.